Cooling survivors of cardiac arrest below normal body temperature does not improve patient survival or recovery.
MRINZ trials win five of the seven Australian Clinical Trials Alliance (ACTA) 2021 Awards
ICU, interview, news, publication, announcement, PleuralDiseaseGuest UserICU, intensive care, awards, Australia, ACTA, PleuralDisease
Preliminary findings show arthritis drug to be effective in treating sickest COVID-19 patients